NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition
Angela Kim, Prateek Bhardwaj, Collin D. Heer, Sophia J. Zhao, Karlie N. Lucas, Katelyn J. Noronha, Sam Friedman, Raffaella Morotti, Ranjini K. Sundaram, Shahyan Rehman, Deepti Bhatt, Filemon S. Dela Cruz, Tamar Y. Feinberg, Subhash Ramakrishnan, Wei Xue, , Juan C. Vasquez
This study evaluates NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitor therapy.
Molecular Cancer Therapeutics · Apr 22, 2026Peer-reviewedCancer Biology